Koji Yasuda
Principal Fast Track Initiative Inc
Koji Yasuda is a Principal at Fast Track Initiative (FTI), where he focuses on NewCo creation and early-stage biotech investments, with an emphasis on building cross-border companies originating in Japan and scaling globally. He is actively involved as a board director or observer across multiple portfolio companies, including cell therapy companies such as RegCell and Shinobi Therapeutics.
Seminars
Tuesday 15th September 2026
Pharma & Investor Roundtable Discussions
2:00 pm
- Connect directly with leading experts in an interactive roundtable setting, sharing your work and showcasing your assets in focused, face-to-face conversations
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration
- For biotech, gain actionable insights by hearing what your peers are developing and understand first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
Thursday 17th September 2026
Investors Panel Discussion: Shaping Cell Therapy Funding & Partnerships with Investor Perspectives
8:30 am
- Evaluating funding and investment in cell therapy to uncover future investment interests
- Highlighting key considerations for investment, discussing technology leverage, data packages and more to align priorities and biopharma development strategy
- Facilitating open dialogue to accelerate partnership decisions and investment success in the cell therapy space
